Related Experiment Video

Updated: Jul 7, 2026

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
08:00

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation

Published on: October 4, 2024

Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase

Fubo Liang1, Yong Luo, Yuanshu Dong

  • 1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

The Journal of Biological Chemistry
|February 13, 2008
PubMed

Insights

Phosphatase of regenerating liver 3 (PRL3) down-regulates Csk protein synthesis by increasing eIF2 phosphorylation. This mechanism impacts cancer metastasis and Src kinase activity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Phosphatase of regenerating liver 3 (PRL3) is upregulated in cancer metastases.
  • Elevated PRL3 expression is linked to increased tumorigenesis and metastasis, potentially via Src kinase activation.
  • The precise mechanism of PRL3-mediated regulation of Src activity, particularly Csk (a Src negative regulator), remains unclear.

Purpose of the Study:

  • To elucidate the mechanism by which PRL3 mediates the downregulation of Csk.
  • To investigate the role of PRL3 in controlling Src kinase activity in the context of cancer metastasis.

Main Methods:

  • Analysis of Csk protein and mRNA levels in response to PRL3 expression.
  • Investigation of the impact of PRL3 on protein synthesis and turnover.
  • Assessment of eIF2 phosphorylation levels in cells expressing PRL3.

Main Results:

  • PRL3 downregulates Csk protein levels, not by affecting mRNA or protein turnover, but by inhibiting Csk protein synthesis.
  • PRL3 expression leads to increased eIF2 phosphorylation, which is responsible for the reduced Csk synthesis.
  • This translational control mechanism is similar to that observed under cellular stress conditions.

Conclusions:

  • PRL3 exerts gene-specific translational control over Csk expression.
  • This novel mechanism highlights PRL3's role in regulating cellular signaling pathways crucial for cancer metastasis.
  • The findings suggest a broader role for this regulatory mechanism in response to various cellular conditions.

More Related Videos

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...